Oncoclinicas do Brasil Servicos Medicos SA(BR:ONCO3)
R$0.68-0.04 (-5.56%)
BR:ONCO3
Oncoclinicas do Brasil Servicos Medicos SA financials statements
R$0.68
At close:-0.04 (-5.56%)
Oncoclinicas do Brasil Servicos Medicos SA (ONCO3) Ratios
Oncoclinicas do Brasil Servicos Medicos SA Ratios
BR:ONCO3's free cash flow for Q2 2026 was R$107.25M. For the 2026 fiscal year, BR:ONCO3's free cash flow was decreased by R$-15.57M and operating cash flow was R$122.82M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.56 | 1.90 | 1.71 | 1.50 | 2.41 |
| Quick Ratio | 0.52 | 1.81 | 1.60 | 1.41 | 2.35 |
| Cash Ratio | 0.10 | 0.22 | 0.30 | 0.14 | 0.45 |
| Solvency Ratio | -0.55 | -0.04 | 0.07 | 0.04 | 0.02 |
| Operating Cash Flow Ratio | -0.02 | -0.08 | -0.03 | -0.14 | -0.01 |
| Short-Term Operating Cash Flow Coverage | -0.04 | -0.24 | -0.13 | -0.80 | -0.03 |
| Net Current Asset Value | R$ -3.17B | R$ -3.16B | R$ -3.40B | R$ -2.76B | R$ -856.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.49 | 0.50 | 0.42 | 0.40 |
| Debt-to-Equity Ratio | 4.22 | 1.74 | 1.98 | 1.64 | 1.31 |
| Debt-to-Capital Ratio | 0.81 | 0.64 | 0.66 | 0.62 | 0.57 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.57 | 0.62 | 0.57 | 0.49 |
| Financial Leverage Ratio | 7.91 | 3.56 | 3.99 | 3.88 | 3.25 |
| Debt Service Coverage Ratio | -0.72 | 0.16 | 1.17 | 0.89 | 0.51 |
| Interest Coverage Ratio | -3.88 | -0.20 | 1.35 | 1.09 | 1.15 |
| Debt to Market Cap | 1.80 | 3.41 | 0.63 | 1.12 | 0.40 |
| Interest Debt Per Share | 6.58 | 9.86 | 9.77 | 8.14 | 5.44 |
| Net Debt to EBITDA | -1.48 | 18.17 | 3.58 | 4.63 | 5.50 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.12% | 33.09% | 35.14% | 35.52% | 32.15% |
| EBIT Margin | -44.02% | -0.89% | 15.71% | 12.67% | 8.02% |
| EBITDA Margin | -38.84% | 4.36% | 20.40% | 16.96% | 12.72% |
| Operating Profit Margin | -42.98% | -1.93% | 13.81% | 11.51% | 6.56% |
| Pretax Profit Margin | -55.10% | -10.55% | 5.51% | 2.97% | 2.31% |
| Net Profit Margin | -63.14% | -10.38% | 4.07% | 1.13% | -1.74% |
| Continuous Operations Profit Margin | -63.96% | -11.52% | 5.69% | 2.78% | -0.83% |
| Net Income Per EBT | 114.58% | 98.38% | 73.92% | 38.06% | -75.24% |
| EBT Per EBIT | 128.22% | 547.62% | 39.91% | 25.83% | 35.18% |
| Return on Assets (ROA) | -50.82% | -5.77% | 2.44% | 0.56% | -0.78% |
| Return on Equity (ROE) | -402.23% | -20.54% | 9.72% | 2.18% | -2.53% |
| Return on Capital Employed (ROCE) | -127.89% | -1.37% | 10.29% | 7.43% | 3.66% |
| Return on Invested Capital (ROIC) | -47.87% | -1.25% | 9.67% | 6.54% | -1.22% |
| Return on Tangible Assets | -81.47% | -8.67% | 4.48% | 1.07% | -1.24% |
| Earnings Yield | -198.38% | -44.80% | 3.42% | 1.67% | -0.88% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.85 | 3.04 | 2.96 | 2.96 | 4.06 |
| Payables Turnover | 3.60 | 4.09 | 4.48 | 4.36 | 4.29 |
| Inventory Turnover | 21.31 | 18.50 | 17.25 | 16.08 | 26.44 |
| Fixed Asset Turnover | 5.21 | 4.66 | 4.44 | 3.75 | 3.71 |
| Asset Turnover | 0.80 | 0.56 | 0.60 | 0.50 | 0.45 |
| Working Capital Turnover Ratio | -116.97 | 3.56 | 4.92 | 3.12 | 2.59 |
| Cash Conversion Cycle | 10.58 | 50.52 | 63.12 | 62.13 | 18.71 |
| Days of Sales Outstanding | 94.76 | 120.10 | 123.50 | 123.17 | 89.98 |
| Days of Inventory Outstanding | 17.13 | 19.73 | 21.16 | 22.70 | 13.80 |
| Days of Payables Outstanding | 101.30 | 89.31 | 81.55 | 83.74 | 85.08 |
| Operating Cycle | 111.88 | 139.83 | 144.66 | 145.87 | 103.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.18 | -0.30 | -0.10 | -0.57 | -0.02 |
| Free Cash Flow Per Share | -0.43 | -0.65 | -0.69 | -1.19 | -0.44 |
| Dividend Paid and CapEx Coverage Ratio | -0.58 | -0.82 | -0.14 | -0.85 | -0.04 |
| Capital Expenditure Coverage Ratio | -0.71 | -0.86 | -0.17 | -0.90 | -0.05 |
| Operating Cash Flow Coverage Ratio | -0.03 | -0.03 | -0.01 | -0.08 | -0.00 |
| Operating Cash Flow to Sales Ratio | -0.02 | -0.03 | -0.01 | -0.07 | -0.00 |
| Free Cash Flow Yield | -15.70% | -27.67% | -5.55% | -20.58% | -3.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.50 | -2.23 | 29.27 | 60.06 | -113.89 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.23 | 1.19 | 0.68 | 1.98 |
| Price-to-Book (P/B) Ratio | 2.03 | 0.46 | 2.84 | 1.31 | 2.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.37 | -3.61 | -18.02 | -4.86 | -25.29 |
| Price-to-Operating Cash Flow Ratio | -15.40 | -7.80 | -126.95 | -10.23 | -575.39 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.01 | 0.08 | -0.30 | 1.53 |
| Enterprise Value Multiple | -2.30 | 23.48 | 9.42 | 8.64 | 21.04 |
| Enterprise Value | 5.12B | 6.37B | 10.55B | 5.99B | 7.23B |
| EV to EBITDA | -2.30 | 23.48 | 9.42 | 8.64 | 21.04 |
| EV to Sales | 0.89 | 1.02 | 1.92 | 1.46 | 2.68 |
| EV to Free Cash Flow | -17.84 | -15.96 | -29.04 | -10.47 | -34.24 |
| EV to Operating Cash Flow | -43.13 | -34.46 | -204.61 | -22.05 | -779.09 |
| Tangible Book Value Per Share | -2.40 | -0.60 | -2.89 | -2.67 | 0.14 |
| Shareholders’ Equity Per Share | 1.34 | 5.10 | 4.39 | 4.41 | 3.90 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.16 | -0.09 | -0.03 | 0.06 | 1.36 |
| Revenue Per Share | 8.51 | 10.10 | 10.48 | 8.52 | 5.69 |
| Net Income Per Share | -5.38 | -1.05 | 0.43 | 0.10 | -0.10 |
| Tax Burden | 1.15 | 0.98 | 0.74 | 0.38 | -0.75 |
| Interest Burden | 1.25 | 11.91 | 0.35 | 0.23 | 0.29 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.24 | 0.22 | 0.21 | 0.24 | 0.25 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.03 |
| Income Quality | 0.03 | 0.26 | -0.23 | -2.39 | 0.41 |
Currency in BRL
